In a move to coincide with April 20 (4/20), 10 Pennsylvania Democrats are proposing that the federal government deschedule cannabis as a controlled substance.

Chief sponsors Rep. Christopher Rabb (D-Philadelphia) and Rep. Danilo Burgos (D-Philadelphia) noted in their co-sponsorship memoranda that Schedule I drugs such as cannabis are defined by the United States government as having a high potential for abuse and no currently accepted medical use.

Schedule I substances include substances such as heroin, LSD, and ecstasy. Cannabis, though, is regulated and used medicinally in 38 states and the District of Columbia, while 21 states permit adult use recreationally.

Gov. Josh Shapiro on Wednesday directed his Department of Health to send a notice of intent to include xylazine, or ‘tranq’ as it is also known as, as a Schedule III drug.

Cannabis, on the flip side, is being recognized by states as a low-risk, medically necessary substance, but remains on the schedule list.

Eight other Democratic lawmakers have signed onto the bill, including Rep. Carol Hill-Evans (D-York), Rep. Joseph C. Hohenstein (D-Philadelphia), Rep. Malcolm Kenyatta (D-Philadelphia), Rep. Maureen E. Madden (D-Monroe), Rep. Jeanne McNeill (D-Lehigh), Rep. Darisha K. Parker (D-Philadelphia), Rep. Benjamin V. Sanchez (D-Montgomery) and Rep. Michael H. Schlossberg (D-Lehigh).

The resolution urges the federal government to remove cannabis from Schedule I. In doing so “would facilitate medical research, ensure patient access, and remove federal prohibitions. Countless lives would be improved and billions would be saved by reducing the unnecessary incarceration of individuals arrested for low-level cannabis offenses.”